PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
PetVivo Holdings, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $27.79M
- P/E (TTM)
- –
- Dividend yield
- –
PetVivo Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q1 27 | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales to Vedco [Member] | $845.40K | $809.16K | $642.84K | $555.58K | $328.08K | $288.93K | – | – | – | – | – | – | 71.5% | +157.7% |
| Product [Member] | – | $0 | $8.45K | $211.19K | $389.03K | $430.82K | $448.15K | $685.33K | $658.65K | $626.18K | $686.46K | $703.04K | – | – |
| Sales to Convetrus [Member] | – | $0 | $8.80K | $26.41K | $26.41K | $44.02K | – | – | – | – | – | – | – | – |
| Sales To Clipper [Member] | – | $40.52K | – | – | – | $194.50K | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of PetVivo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.